Evaluating Antigen- and Vector-Specific Immune Responses of a Recombinant Pichinde Virus-Based Vaccine Expressing the Lymphocytic Choriomeningitis Virus Nucleoprotein

Bibliographic Details
Title: Evaluating Antigen- and Vector-Specific Immune Responses of a Recombinant Pichinde Virus-Based Vaccine Expressing the Lymphocytic Choriomeningitis Virus Nucleoprotein
Authors: Michaela Cain, Qinfeng Huang, Shania Sanchez, Hinh Ly, Yuying Liang
Source: Vaccines, Vol 12, Iss 12, p 1450 (2024)
Publisher Information: MDPI AG, 2024.
Publication Year: 2024
Collection: LCC:Medicine
Subject Terms: arenavirus, Pichinde virus, LCMV, vaccine, viral vector, vaccine immunity, Medicine
More Details: Background: Live viral vector-based vaccines are known to elicit strong immune responses, but their use can be limited by anti-vector immunity. Here, we analyzed the immunological responses of a live-attenuated recombinant Pichinde virus (PICV) vector platform (rP18tri). Methods: To evaluate anti-PICV immunity in the development of vaccine antigen-specific immune responses, we generated a rP18tri-based vaccine expressing the lymphocytic choriomeningitis virus (LCMV) nucleoprotein (NP) and administered four doses of this rP18tri-NPLCMV vaccine to mice. Using MHC-I tetramers to detect PICV NP38-45 and LCMV NP396-404 epitope-specific CD8+ T cells, we monitored vector- and vaccine-antigen-specific immune responses after each vaccination dose. Results: LCMV NP396-404-specific effector and memory CD8+ T cells were detected after the first dose and peaked after the second dose, whereas PICV NP38-45-specific memory CD8+ T cells increased with each dose. PICV-binding IgG antibodies peaked after the second dose, while anti-PICV neutralizing antibodies (NAbs) remained low even after the fourth dose. Immunization with the rP18tri-NPLCMV vaccine significantly reduced LCMV viral titers in a chronic LCMV Clone 13 infection model, demonstrating the protective role of LCMV NP-specific T cells. Conclusion: These findings provide important insights into the antigen- and vector-specific immunity of the rP18tri-NPLCMV vaccine and support the development of NP-based vaccines against arenavirus pathogens.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2076-393X
Relation: https://www.mdpi.com/2076-393X/12/12/1450; https://doaj.org/toc/2076-393X
DOI: 10.3390/vaccines12121450
Access URL: https://doaj.org/article/a814d72afdb1446fa4ae428de963cf1d
Accession Number: edsdoj.814d72afdb1446fa4ae428de963cf1d
Database: Directory of Open Access Journals
More Details
ISSN:2076393X
DOI:10.3390/vaccines12121450
Published in:Vaccines
Language:English